Table 2 Demographic and clinical characteristics of participants by CAP Score quartiles
Variables | CAP Score (dB/m) | P-value Between group | |||
|---|---|---|---|---|---|
Q1 [180.0-265.0, n = 37] | Q2 [266.0-300.0, n = 38] | Q3 [301.0-326.0, n = 36] | Q4 [327.0-400.0, n = 36] | ||
Age (year) | 56.84 ± 8.6 | 54.05 ± 10.0 | 56.86 ± 6.2 | 54.67 ± 5.6 | 0.29 |
BMI (kg/m2) | 26.40 (24.60–28.40) | 28.85 (26.50–30.50) | 28.75 (27.50–31.10) | 31.35 (29.00-33.65) | < 0.001 |
SBP (mmHg) | 120.0 (110.0-125.5) | 120.0 (110.0-120.0) | 120.0 (110.0-127.0) | 126.5 (119.0-132.5) | 0.005 |
DBP (mmHg) | 80.0 (80.0–80.0) | 80.0 (80.0–80.0) | 80.0 (76.0–80.0) | 80.0 (80.0–90.0) | 0.07 |
FBG (mg/dl) | 141.0 (115.0-161.0) | 139.5 (108.0-171.0) | 130.0 (109.0-160.5) | 132.5 (115.0-157.0) | 0.95 |
HbA1C (%) | 7.4 (6.3–8.5) | 7.4 (6.8-8.0) | 7.1 (6.2–7.9) | 7.2 (6.8–8.5) | 0.22 |
TG (mg/dl) | 109.0 (85.0-141.0) | 143.0 (117.0-186.0) | 151.5 (113.0-210.0) | 182.0 (118.5–236.0) | 0.001 |
Total chol. (mg/dl) | 127.0 (107.0-169.0) | 143.0 (116.0-177.0) | 134.0 (114.5-160.5) | 155.5 (131.5-180.50) | 0.03 |
LDL-chol.(mg/dl) | 67.43 ± 23.22 | 74.45 ± 25.84 | 68.61 ± 22.40 | 77.72 ± 24.53 | 0.22 |
HDL-chol.(mg/dl) | 51.0 (44.0–59.0) | 51.5 (43.0–60.0) | 49.0 (39.5–53.0) | 44.5 (40.5–56.5) | 0.08 |
ALT (IU/l) | 18.0 (13.0–26.0) | 18.5 (15.0–23.0) | 23.0 (17.5–29.0) | 26.5 (20.0-31.5) | 0.002 |
AST (IU/l) | 19.0 (16.0–25.0) | 18.0 (16.0–22.0) | 19.0 (17.5–25.0) | 22.0 (18.5–27.5) | 0.08 |
eGFR (mL/min/1.73m2) | 69.49 (61.34–77.75) | 74.10 (67.95–80.20) | 73.43 (60.08–84.47) | 72.47 (64.48–80.81) | 0.83 |
CAP Score (dB/m) | 245.0 (235.0-260.0) | 280.0 (270.0-290.0) | 316.0 (310.0-320.0) | 340.0 (330.0-360.0) | < 0.001 |
FMD Brachial (%) | 5.00 (2.04–9.09) | 6.35 (2.27–12.24) | 3.89 (0.92-6.00) | 4.49 (0.98–7.29) | 0.11 |
Paradoxical vasoconstriction (%) | 3 (8.1%) | 3 (7.9%) | 3 (8.3%) | 6 (16.7%) | 0.54 |